logologo

  • Home
  • About Us
  • About EpiDOSE
    • Key Facts
  • For Patients & Families
    • Follow Up Interview
  • For Investigators & EMS
  • For EDs
  • Resources
  • Glossary
  • News
  • Contact

logologo

  • Home
  • About Us
  • About EpiDOSE
    • Key Facts
  • For Patients & Families
    • Follow Up Interview
  • For Investigators & EMS
  • For EDs
  • Resources
  • Glossary
  • News
  • Contact
  • Home
  • About Us
  • About EpiDOSE
    • Key Facts
  • For Patients & Families
    • Follow Up Interview
  • For Investigators & EMS
  • For EDs
  • Resources
  • Glossary
  • News
  • Contact

About EpiDOSE

Cardiac Arrest is a life threatening event

Each year in Canada, there are over 40,000 people who collapse from cardiac arrest. Sudden cardiac arrest happens when the heart suddenly and unexpectedly stops beating, reducing blood flow to the brain and other vital organs. Causes of cardiac arrest include dangerous and irregular heart rhythms that cause blockages in the arteries that supply blood to the heart, as well as other causes that do not affect the heart like illegal drugs or motor vehicle accidents.

This life-threatening event is treated by paramedics with cardiopulmonary resuscitation, defibrillator shocks, and drugs, including the routine use of a medication called epinephrine (adrenaline). Epinephrine can help reverse cardiac arrest by increasing blood flow to the heart and other organs. In Canada, the standard dose given by paramedics is 1mg of epinephrine every 3 to 5 minutes. Although the standard dose of epinephrine can help restart the heart in the short term, many patients will not survive to leave the hospital from causes like irreversible brain injury and brain death.

Even though epinephrine has been used for decades, there is limited proof that the standard dose of epinephrine is effective in the long term at improving long-term outcomes such as survival following hospital discharge. There has been some research to suggest that a lower dose of epinephrine may improve long-term outcomes, but more research is needed to determine this.

The objective

The objective of the EpiDOSE clinical trial is to improve patient outcomes by evaluating how we currently use epinephrine during resuscitation. The EpiDOSE trial will test how effective a lower dose of epinephrine is (up to 2 doses or 2mg total) compared to the current standard dose of epinephrine (up to 6 doses or 6mg total) on survival to hospital discharge in adults who experience an out-of-hospital cardiac arrest. The study will involve Emergency Medical Service agencies in British Columbia and Ontario.

EpiDOSE will be the first clinical trial to test the effects of a low total dose of epinephrine compared to a standard total dose of epinephrine in cardiac arrest. There has been some research to suggest that a lower dose of epinephrine may improve long-term outcomes, but more research is needed to determine this. Results from this research may change cardiac arrest treatment in Canada and worldwide.

Study Participation

This trial includes adults aged 18 years and older, who experience an out-of-hospital cardiac arrest from irregular heart rhythms of ventricular fibrillation and pulseless ventricular tachycardia in areas serviced by participating emergency medical services agencies.

If you or your loved one was enrolled in EpiDOSE visit here.

EpiDOSE at St. Michael’s Hospital

30 Bond Street Toronto, ON, Canada M5B 1W8

Telephone: 416-864-6060

Email: epidose@unityhealth.to

Congrats to @essexwindsorems for enrolling their f Congrats to @essexwindsorems for enrolling their first #EpiDOSE patient! 🎉
Congrats to @essexwindsorems on successfully launc Congrats to @essexwindsorems on successfully launching #EpiDOSE today! 🎉
Congratulations @superiornorthems for officially l Congratulations @superiornorthems for officially launching the #EpiDOSE trial today! 🎉🎉
Congratulations! @london_paramedics_147 joined #Ep Congratulations! @london_paramedics_147 joined #EpiDOSE and officially enrolled their first patient on their first day! 🎉 Way to go!
Congratulations! 🎉 Earlier this year, @haltonpa Congratulations! 🎉 Earlier this year, @haltonparamedicunion @bc_ehs and @ottawa_paramedic_service all successfully transitioned from study drug kits to our new randomization envelopes! #EpiDOSE
As of earlier this year, the #EpiDOSE trial has of As of earlier this year, the #EpiDOSE trial has officially switched over to using randomization kits! Randomization kits no longer include study drug, and medics are asked to use their own clinical supply instead.
EpiDOSE has now enrolled a total of 137 participan EpiDOSE has now enrolled a total of 137 participants! #EpiDOSE
Our #Epi article was one the of 5 most downloaded Our #Epi article was one the of 5 most downloaded articles in the Canadian Journal of Emergency Medicine (CJEM) in 2019! 👏 #epidose #cjem
We’re blowing up on twitter! Make sure to follow We’re blowing up on twitter! Make sure to follow us if you haven’t done so already #EpiDOSE
Thank you to Professor Tom Quinn for his mention o Thank you to Professor Tom Quinn for his mention of #EpiDOSE in his presentation at the #ESCcongress #WCC2019 @europeansocietyofcardiology
Be sure to follow us on twitter for updates about Be sure to follow us on twitter for updates about the #epidose trial!
Heart attack vs. cardiac arrest. Know the differen Heart attack vs. cardiac arrest. Know the difference, it can save a life. #epidose
Wondering what sudden cardiac arrest is? Wonder no Wondering what sudden cardiac arrest is? Wonder no more. #epidose
Each year in Canada, there are over 40,000 people Each year in Canada, there are over 40,000 people who collapse from cardiac arrest. 8 in 10 cardiac arrests occur at home or in public places. However, only 1 in 10 survive cardiac arrests that happen outside of the hospital. #epidose
Hello and welcome to EpiDOSE 👋! The study that Hello and welcome to EpiDOSE 👋! The study that aims to evaluate optimal vs. standard doses of epinephrine in out of hospital cardiac arrest patients. Follow us along on our journey to make patient care better.
Follow on Instagram

© 2023 EpiDOSE at St. Michael's Hospital. All Rights Reserved.   Privacy Policy   Developed by Globalgraphics